267 related articles for article (PubMed ID: 18243568)
21. Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice.
Nomura M; Saito J; Ueta Y; Muglia LJ; Pfaff DW; Ogawa S
J Neuroendocrinol; 2003 Nov; 15(11):1054-61. PubMed ID: 14622435
[TBL] [Abstract][Full Text] [Related]
22. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
Al-Barazanji KA; Wilson S; Baker J; Jessop DS; Harbuz MS
J Neuroendocrinol; 2001 May; 13(5):421-4. PubMed ID: 11328451
[TBL] [Abstract][Full Text] [Related]
23. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
Dakine N; Oliver C; Grino M
J Neuroendocrinol; 2000 Aug; 12(8):774-83. PubMed ID: 10929090
[TBL] [Abstract][Full Text] [Related]
24. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.
Schwartz MW; Strack AM; Dallman MF
Regul Pept; 1997 Oct; 72(2-3):105-12. PubMed ID: 9652969
[TBL] [Abstract][Full Text] [Related]
25. Independent and overlapping effects of corticosterone and testosterone on corticotropin-releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus of the hypothalamus and stress-induced adrenocorticotropic hormone release.
Viau V; Chu A; Soriano L; Dallman MF
J Neurosci; 1999 Aug; 19(15):6684-93. PubMed ID: 10414997
[TBL] [Abstract][Full Text] [Related]
26. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
[TBL] [Abstract][Full Text] [Related]
27. Gender difference in hypothalamic-pituitary-adrenal axis response to alcohol in the rat: activational role of gonadal steroids.
Ogilvie KM; Rivier C
Brain Res; 1997 Aug; 766(1-2):19-28. PubMed ID: 9359583
[TBL] [Abstract][Full Text] [Related]
28. Oxytocin actions within the supraoptic and paraventricular nuclei: differential effects on peripheral and intranuclear vasopressin release.
Neumann ID; Torner L; Toschi N; Veenema AH
Am J Physiol Regul Integr Comp Physiol; 2006 Jul; 291(1):R29-36. PubMed ID: 16424083
[TBL] [Abstract][Full Text] [Related]
29. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
Zelena D; Mergl Z; Makara GB
Brain Res; 2005 Jan; 1031(2):185-93. PubMed ID: 15649443
[TBL] [Abstract][Full Text] [Related]
30. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
[TBL] [Abstract][Full Text] [Related]
31. Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion?
Wotjak CT; Kubota M; Liebsch G; Montkowski A; Holsboer F; Neumann I; Landgraf R
J Neurosci; 1996 Dec; 16(23):7725-32. PubMed ID: 8922428
[TBL] [Abstract][Full Text] [Related]
32. Vasopressin as a target for antidepressant development: an assessment of the available evidence.
Scott LV; Dinan TG
J Affect Disord; 2002 Nov; 72(2):113-24. PubMed ID: 12200202
[TBL] [Abstract][Full Text] [Related]
33. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR
Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768
[TBL] [Abstract][Full Text] [Related]
34. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
35. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
Kakui N; Kitamura K
Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
[TBL] [Abstract][Full Text] [Related]
36. Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids.
Müller MB; Landgraf R; Preil J; Sillaber I; Kresse AE; Keck ME; Zimmermann S; Holsboer F; Wurst W
Endocrinology; 2000 Nov; 141(11):4262-9. PubMed ID: 11089561
[TBL] [Abstract][Full Text] [Related]
37. Attenuation of hypothalamic-pituitary-adrenal axis stress responses in late pregnancy: changes in feedforward and feedback mechanisms.
Johnstone HA; Wigger A; Douglas AJ; Neumann ID; Landgraf R; Seckl JR; Russell JA
J Neuroendocrinol; 2000 Aug; 12(8):811-22. PubMed ID: 10929094
[TBL] [Abstract][Full Text] [Related]
38. Hypothalamic-pituitary-adrenal axis hyporesponsiveness to restraint stress in mice deficient for large-conductance calcium- and voltage-activated potassium (BK) channels.
Brunton PJ; Sausbier M; Wietzorrek G; Sausbier U; Knaus HG; Russell JA; Ruth P; Shipston MJ
Endocrinology; 2007 Nov; 148(11):5496-506. PubMed ID: 17656462
[TBL] [Abstract][Full Text] [Related]
39. Effects of prenatal ethanol exposure on basal limbic-hypothalamic-pituitary-adrenal regulation: role of corticosterone.
Glavas MM; Ellis L; Yu WK; Weinberg J
Alcohol Clin Exp Res; 2007 Sep; 31(9):1598-610. PubMed ID: 17760789
[TBL] [Abstract][Full Text] [Related]
40. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
